216 related articles for article (PubMed ID: 25428529)
1. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: an updated meta-analysis.
Li D; Zhou M; Peng X; Sun H
BMC Ophthalmol; 2014 Nov; 14():147. PubMed ID: 25428529
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis.
McGimpsey SJ; Woodside JV; Cardwell C; Cahill M; Chakravarthy U
Ophthalmology; 2009 Sep; 116(9):1778-1787.e1. PubMed ID: 19729099
[TBL] [Abstract][Full Text] [Related]
3. Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype.
McGimpsey SJ; Woodside JV; Bamford L; Gilchrist SE; Graydon R; McKeeman GC; Young IS; Hughes AE; Patterson CC; O'Reilly D; McGibbon D; Chakravarthy U
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4712-6. PubMed ID: 16303969
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease.
Cahill MT; Stinnett SS; Fekrat S
Am J Ophthalmol; 2003 Dec; 136(6):1136-50. PubMed ID: 14644226
[TBL] [Abstract][Full Text] [Related]
5. Plasma homocysteine in patients with retinal vein occlusion.
Minniti G; Calevo MG; Giannattasio A; Camicione P; Armani U; Lorini R; Piana G
Eur J Ophthalmol; 2014; 24(5):735-43. PubMed ID: 24519513
[TBL] [Abstract][Full Text] [Related]
6. Thermolabile MTHFR genotype and retinal vascular occlusive disease.
Cahill M; Karabatzaki M; Donoghue C; Meleady R; Mynett-Johnson LA; Mooney D; Graham IM; Whitehead AS; Shields DC
Br J Ophthalmol; 2001 Jan; 85(1):88-90. PubMed ID: 11133719
[TBL] [Abstract][Full Text] [Related]
7. Plasma homocysteine levels, methylene tetrahydrofolate reductase A1298C gene polymorphism and risk of retinal vein thrombosis.
Ghaznavi H; Soheili Z; Samiei S; Soltanpour MS
Blood Coagul Fibrinolysis; 2016 Sep; 27(6):679-83. PubMed ID: 26650461
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine, B vitamins, methylenetetrahydrofolate reductase gene, and risk of primary open-angle glaucoma: a meta-analysis.
Xu F; Zhao X; Zeng SM; Li L; Zhong HB; Li M
Ophthalmology; 2012 Dec; 119(12):2493-9. PubMed ID: 22902176
[TBL] [Abstract][Full Text] [Related]
9. Association of retinal vein occlusion, homocysteine, and the thrombophilic mutations in a Turkish population: A case-control study.
Koylu MT; Kucukevcilioglu M; Erdurman FC; Durukan AH; Sobacı G; Torun D; Tunca Y; Ayyildiz O
Ophthalmic Genet; 2017; 38(4):352-356. PubMed ID: 28085519
[TBL] [Abstract][Full Text] [Related]
10. Association of methylenetetrahydrofolate reductase (A1298C and C677T) polymorphisms with retinal vein occlusion in Tunisian patients.
Mrad M; Wathek C; Saleh MB; Baatour M; Rannen R; Lamine K; Gabsi S; Gritli N; Fekih-Mrissa N
Transfus Apher Sci; 2014 Apr; 50(2):283-7. PubMed ID: 24440586
[TBL] [Abstract][Full Text] [Related]
11. Plasma Homocysteine, Serum Folic Acid, Serum Vitamin B12, Serum Vitamin B6, MTHFR, and Risk of Normal-Tension Glaucoma.
Li J; Xu F; Zeng R; Gong H; Lan Y
J Glaucoma; 2016 Feb; 25(2):e94-8. PubMed ID: 26171850
[TBL] [Abstract][Full Text] [Related]
12. Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion.
Marcucci R; Giusti B; Betti I; Evangelisti L; Fedi S; Sodi A; Cappelli S; Menchini U; Abbate R; Prisco D
Thromb Res; 2003 Apr; 110(1):7-12. PubMed ID: 12877902
[TBL] [Abstract][Full Text] [Related]
13. Association study of high-frequency variants of
Fernández-Vega B; Álvarez L; García M; Artime E; González Fernández A; Fernández-Vega C; Nicieza J; Vega JA; González-Iglesias H
Ophthalmic Genet; 2019 Aug; 40(4):342-349. PubMed ID: 31418317
[No Abstract] [Full Text] [Related]
14. Plasma homocysteine concentrations in acute and convalescent changes of central retinal vein occlusion in a Chinese population.
Dong N; Xu B; Tang X
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4057-62. PubMed ID: 24906854
[TBL] [Abstract][Full Text] [Related]
15. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
Cruciani F; Moramarco A; Curto T; Labate A; Recupero V; Conti L; Gandolfo GM; Balacco Gabrieli C
Clin Ter; 2003; 154(5):299-303. PubMed ID: 14994919
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms associated with retinal vein occlusion: a Greek case-control study and meta-analysis.
Yioti GG; Panagiotou OA; Vartholomatos GA; Kolaitis NI; Pappa CN; Evangelou E; Stefaniotou MI
Ophthalmic Genet; 2013 Sep; 34(3):130-9. PubMed ID: 23289804
[TBL] [Abstract][Full Text] [Related]
17. Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion.
Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Quehenberger F; Semmelrock J; Haas A
Ophthalmology; 2002 Jun; 109(6):1105-9. PubMed ID: 12045051
[TBL] [Abstract][Full Text] [Related]
18. Contribution of thermolabile methylenetetrahydrofolate reductase variant to total plasma homocysteine levels in healthy men and women. Inter99 (2).
Husemoen LL; Thomsen TF; Fenger M; Jørgensen HL; Jørgensen T
Genet Epidemiol; 2003 May; 24(4):322-30. PubMed ID: 12687650
[TBL] [Abstract][Full Text] [Related]
19. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
[TBL] [Abstract][Full Text] [Related]
20. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
Soares AL; Fernandes AP; Cardoso JE; Sousa MO; Lasmar MC; Novelli BA; Lages GF; Dusse LM; Vieira LM; Lwaleed BA; Carvalho MG
Pathophysiol Haemost Thromb; 2008; 36(5):275-81. PubMed ID: 19996639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
